Usefulness of Functional Thyroid-Stimulating and Thyroid-Blocking Immunoglobulin Bioassays in an Atypical Presentation of Graves’ Disease
Background/Objective: Thyroid-stimulating hormone (TSH) receptor antibody (TRAb) is well recognized as the pathogenic antibody that causes the clinical manifestation of Graves’ disease (GD). Although the majority of TRAb measured in GD is due to thyroid-stimulating immunoglobulin (TSI), there are ot...
Main Authors: | Julie Sherfan, MScMed, MAACB, Navira Samad, MBBS, Albert Hsieh, MBBS, BSc, MMed, PhD, David Sullivan, MBBS, Peter J. Fuller, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-05-01
|
Series: | AACE Clinical Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060523000081 |
Similar Items
-
The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
by: Jin Yu, et al.
Published: (2023-06-01) -
The role of primary cilia in thyroid diseases
by: Zijiao Tian, et al.
Published: (2024-01-01) -
The Thyroid Hormone and Immunoglobulin Concentrations in Blood Serum and Thyroid Gland Morphology in Young Hens Fed with Different Diets, Sources, and Levels of Iodine Supply
by: Maja Słupczyńska, et al.
Published: (2022-12-01) -
Autoimmune Thyroiditis Shifting from Hashimoto’s Thyroiditis to Graves’ Disease
by: Narantsatsral Daramjav, et al.
Published: (2023-04-01) -
Morphological features of thyroid benign focal neoplasms in Graves’ disease
by: Yu.V. Buldygina, et al.
Published: (2022-06-01)